Two biosimilars of Eli Lilly’s blockbuster osteoporosis treatment ... Forsteo (teriparatide) – a bone-building parathyroid hormone drug sold as Forteo in the US – has been a big earner ...

This case study explains how Eli Lilly, the pharmaceuticals company, promoted its 'Forteo' treatment for osteoporosis in Japan, despite barriers including a ban on advertising directly to patients.

Eli Lilly and Company discovers ... it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It operates Lilly Seaport Innovation Center (LSC ...